These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25882195)

  • 1. Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin.
    Franchin C; Salvi M; Arrigoni G; Pinna LA
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1676-86. PubMed ID: 25882195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
    Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
    Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.
    Franchin C; Borgo C; Cesaro L; Zaramella S; Vilardell J; Salvi M; Arrigoni G; Pinna LA
    Cell Mol Life Sci; 2018 Jun; 75(11):2011-2026. PubMed ID: 29119230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
    Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
    Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.
    Cozza G; Venerando A; Sarno S; Pinna LA
    Biomed Res Int; 2015; 2015():734127. PubMed ID: 26558278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
    Gyenis L; Kuś A; Bretner M; Litchfield DW
    J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.
    Venerando A; Franchin C; Cant N; Cozza G; Pagano MA; Tosoni K; Al-Zahrani A; Arrigoni G; Ford RC; Mehta A; Pinna LA
    PLoS One; 2013; 8(9):e74232. PubMed ID: 24058532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CE-based assay for human protein kinase CK2 activity measurement and inhibitor screening.
    Gratz A; Götz C; Jose J
    Electrophoresis; 2010 Jan; 31(4):634-40. PubMed ID: 20162588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
    Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase CK2 regulates metal toxicity in neuronal cells.
    Zaman MS; Johnson AJ; Bobek G; Kueh S; Kersaitis C; Bailey TD; Buskila Y; Wu MJ
    Metallomics; 2016 Jan; 8(1):82-90. PubMed ID: 26623569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP site-directed inhibitors of protein kinase CK2: an update.
    Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
    Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
    Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
    Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
    Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
    Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Phosphoproteomic quantification based on phosphopeptide intensity or occupancy? An evaluation based on casein kinase 2 downstream effects".
    Rodríguez-Ulloa A; Rosales M; Ramos Y; Guirola O; González LJ; Wiśniewski JR; Perera Y; Perea SE; Besada V
    J Proteomics; 2024 Sep; 307():105269. PubMed ID: 39098729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
    Schwind L; Wilhelm N; Kartarius S; Montenarh M; Gorjup E; Götz C
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2207-16. PubMed ID: 26025678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.
    Wilhelm N; Kostelnik K; Götz C; Montenarh M
    Mol Cell Biochem; 2012 Jun; 365(1-2):37-45. PubMed ID: 22270543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.